Acerus Pharmaceuticals Corporation

(ASP:CHI)

By |

Profile

Acerus Pharmaceuticals Corp is Canada-based specialty pharmaceutical company. Principally, it is engaged in the development, manufacture, marketing, and distribution of branded products in men's and women's health. The company markets its product under brand ESTRACE, NATESTO, GYNOFLOR and TEFINA. The ESTRACE brand markets in Canada and is for the symptomatic relief of menopausal symptoms. Its NATESTO is a licensed nasal gel technology for replacement therapy in adult males diagnosed with hypogonadism. GYNOFLOR offers ultra-low dose vaginal estrogen therapy. Its TEFINA brand product is a low-dose nasal testosterone gel treatment in development for female sexual dysfunction.

Contact Information

Website: www.aceruspharma.com
Email: IR@aceruspharma.com
Main Phone: +1 416 679-0771
Address: 2486 Dunwin Drive
State: ON
City / Town: Mississauga
Country: CAN
Postal Code: L5L 1J9

Issuer Information

Exchange: TSX
CEO: Edward Gudaitis
Employees: 23
NAICS: Pharmaceutical Preparation Manufacturing(325412)
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange TSX
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 0.65 0.65 0.65 0.65
Low Target Price Estimate 0.65 0.65 0.65 0.65
Mean Target Price Estimate 0.65 0.65 0.65 0.65
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 05/29/18 05/29/18 05/17/18 05/29/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.3 2.3 2.3 2.3